Marjorie E Zettler

8PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersMolecular targetsSocial epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 14, 2025
Assessment of Objective Response Rate by Investigator vs. Blinded Independent Central Review in Pivotal Trials of Oncology Drugs for Solid Tumor Indications.

Marjorie E Zettler

|Jun 27, 2024
Dose Optimization of Targeted Therapies for Oncologic Indications.

Marjorie E Zettler

|Jul 21, 2023
FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications.

Marjorie E Zettler

|May 05, 2022
The use of real-world evidence to support FDA post-approval study requirements for oncology drugs.

Marjorie E Zettler

|Jan 20, 2022
The RACE for children act at one year: progress in pediatric development of molecularly targeted oncology drugs.

Marjorie E Zettler

|Oct 07, 2021
Impact of social determinants of health on cancer care: a survey of community oncologists.

Marjorie E Zettler, Bruce A Feinberg, Yolaine Jeune-Smith

Pageof 2

Frequent Collaborators

1 joint publications

Bruce A Feinberg

1 joint publications

Eli G Phillips

1 joint publications

Ajeet Gajra

1 joint publications

Jonathan K Kish